Plasminogen activator inhibitor-1 (PAI-1), the primary inhibitor of tissue-type plasminogen activator and urokinase, is known to convert readily to a latent form by insertion of the reactive center loop into a central -sheet. Interaction with vitronectin stabilizes PAI-1 and decreases the rate of conversion to the latent form, but conformational effects of vitronectin on the reactive center loop of PAI-1 have not been documented. Mutant forms of PAI-1 were designed with a cysteine substitution at either position P1 or P9 of the reactive center loop. Labeling of the unique cysteine with a sulfhydrylreactive fluorophore provides a probe that is sensitive to vitronectin binding. Results indicate that the scissile P1-P1 bond of PAI-1 is more solvent exposed upon interaction with vitronectin, whereas the N-terminal portion of the reactive loop does not experience a significant change in its environment. These results were complemented by labeling vitronectin with an argininespecific coumarin probe which compromises heparin binding but does not interfere with PAI-1 binding to the protein. Dissociation constants of approximately 100 nM are calculated for the vitronectin/PAI-1 interaction from titrations using both fluorescent probes. Furthermore, experiments in which PAI-1 failed to compete with heparin for binding to vitronectin argue for separate binding sites for the two ligands on vitronectin.The adhesive glycoprotein, vitronectin, circulates in human plasma at concentrations of 200 -400 g⅐ml Ϫ1 and serves as a regulatory protein in humoral defense mechanisms by interacting with macromolecules in the reaction cascades of coagulation and fibrinolysis (reviewed in Refs. 1-3). The circulating form of vitronectin is a monomer of 72 kDa, and vitronectin is also found in a multimeric form in platelet releasates and in the extracellular matrix (4 -6). The anti-fibrinolytic protein, plasminogen activator inhibitor-1 (PAI-1), 1 is the major inhibitor of tissue-type plasminogen activator and urokinase-type plasminogen activator (7-11, reviewed in Refs. 12, 13). Like other serpins, PAI-1 has a reactive center loop that mimics the substrate of its target proteases (14, 15). The active conformation of PAI-1 is relatively unstable, so that the protein undergoes rapid conversion to a latent conformation which is characterized by the insertion of the reactive center loop into a central -sheet within the molecule (16). Interactions between strands of the -sheet and the reactive loop stabilize this conformation relative to the active conformation, in which the loop is thought to protrude from the surface of the molecule (7, 16).Binding to vitronectin results in a 2-3-fold increase in the half-life of active PAI-1 (17-19). In addition to stabilizing the active conformation of PAI-1, vitronectin also alters the protease specificity of the serpin so that the vitronectin⅐PAI-1 complex is endowed with the additional ability to inhibit thrombin (20,21). A vitronectin-binding site has been localized on the surface of PAI-1 using site-di...
Summary Acute respiratory distress syndrome (ARDS) is characterized by a rapid‐onset respiratory failure with a mortality rate of approximately 40%. This physiologic inflammatory process is mediated by disruption of the alveolar‐vascular interface, leading to pulmonary oedema and impaired oxygen exchange, which often warrants mechanical ventilation to increase survival in the acute setting. One of the least understood aspects of ARDS is the role of the platelets in this process. Platelets, which protect vascular integrity, play a pivotal role in the progression and resolution of ARDS. The recent substantiation of the age‐old theory that megakaryocytes are found in the lungs has rejuvenated interest in and raised new questions about the importance of platelets for pulmonary function. In addition to primary haemostasis, platelets provide a myriad of inflammatory functions that are poised to aid the innate immune system. This review focuses on the evidence for regulatory roles of platelets in pulmonary inflammation, with an emphasis on two receptors, CLEC‐2 and TLT‐1. Studies of these receptors identify novel pathways through which platelets may regulate vascular integrity and inflammation in the lungs, thereby influencing the development of ARDS.
Mammals can discriminate among a large number (> 10,000) of unique odorants. The most highly supported explanation for this ability is that olfactory neurons express a large number of seven transmembrane receptors that are not spatially organized at the level of the olfactory epithelium, but whose axonal projections form a distinct pattern within the olfactory bulb. The odor-induced signaling pathway in olfactory neurons includes a Gs-like protein (G(olf)) that activates a specific adenylyl cyclase (type III) isoform, resulting in elevations of cyclic AMP and subsequent activation of a cyclic nucleotide-gated channel. The channel also can be regulated by cyclic GMP. Recently, an olfactory neuron-specific guanylyl cyclase was discovered in rodents, and subsequently a large family of sensory neuronal guanylyl cyclases was identified in nematodes. These guanylyl cyclases are concentrated in the plasma membrane of the dendritic cilia and contain extracellular domains that retain many of the primary sequence characteristics of guanylyl cyclases known to be receptors for various peptides. Thus, the guanylyl cyclases appear to represent a second family of odorant/pheromone receptors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.